Abstract:ADVERTISEMENT RETURN TO ISSUEPREVAddition/CorrectionNEXTORIGINAL ARTICLEThis notice is a correctionCorrection to "Renal Clearable Bi–Bi2S3 Heterostructure Nanoparticles for Targeting Cancer Theranostics"Lile DongLile DongMore by Lile Dong, Peng ZhangPeng ZhangMore by Peng Zhang, Xiangjian LiuXiangjian LiuMore by Xiangjian Liuhttps://orcid.org/0000-0003-1850-0292, Ruiping DengRuiping DengMore by Ruiping Deng, Kaimin DuKaimin DuMore by Kaimin Du, Jing Feng*Jing FengMore by Jing Fenghttps://orcid.org/0000-0003-2850-0990, and Hongjie Zhang*Hongjie ZhangMore by Hongjie Zhanghttps://orcid.org/0000-0001-5433-8611Cite this: ACS Appl. Mater. Interfaces 2022, 14, 39, 45073–45075Publication Date (Web):September 20, 2022Publication History Received24 August 2022Published online20 September 2022Published inissue 5 October 2022https://pubs.acs.org/doi/10.1021/acsami.2c15244https://doi.org/10.1021/acsami.2c15244correctionACS PublicationsCopyright © 2022 American Chemical Society. This publication is available under these Terms of Use. Request reuse permissions This publication is free to access through this site. Learn MoreArticle Views520Altmetric-Citations-LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail PDF (8 MB) Get e-Alertsclose Get e-Alerts

Correction: Click functionalized biocompatible gadolinium oxide core-shell nanocarriers for imaging of breast cancer cells

Click functionalized biocompatible gadolinium oxide core-shell nanocarriers for imaging of breast cancer cells

Correction: Ce6-Conjugated and Polydopamine-Coated Gold Nanostars with Enhanced Photoacoustic Imaging and Photothermal/photodynamic Therapy to Inhibit Lung Metastasis of Breast Cancer.

Corrigendum: Biodegradable hollowed mesoporous SeO2 nanoplatform loaded with indocyanine green for simultaneous NIR II fluorescence imaging and synergistic breast carcinoma therapy

Correction: Selenium nanoparticle-functionalized injectable chitosan/collagen hydrogels as a novel therapeutic strategy to enhance stem cell osteoblastic differentiation for bone regeneration

Correction: The improved targeting of an aspirin prodrug albumin-based nanosystem for visualizing and inhibiting lung metastasis of breast cancer

Correction: Facile Preparation of Phospholipid-Amorphous Calcium Carbonate Hybrid Nanoparticles: Toward Controllable Burst Drug Release and Enhanced Tumor Penetration.

Correction: A Novel Biocompatible, Simvastatin-Loaded, Bone-Targeting Lipid Nanocarrier for Treating Osteoporosis More Effectively

Correction: Engineering Cu 2− x S-conjugated upconverting nanocomposites for NIR-II light-induced enhanced chemodynamic/photothermal therapy of cancer

Subcellular Organelle-Targeted Nanostructured Lipid Carriers for the Treatment of Metastatic Breast Cancer [Corrigendum]

Correction: MiR-4458-loaded gelatin nanospheres target COL11A1 for DDR2/SRC signaling pathway inactivation to suppress the progression of estrogen receptor-positive breast cancer

Correction: A highly X-ray sensitive iridium prodrug for visualized tumor radiochemotherapy

Correction: Gadolinium-doped carbon dots with high-performance in dual-modal molecular imaging

Corrigendum: Rational design of a Gd(III)–Cu(II) nanobooster for chemodynamic therapy against cancer cells

Correction: Tumor-targeting, enzyme-activated nanoparticles for simultaneous cancer diagnosis and photodynamic therapy

Preparation of AS1411 Aptamer Modified Mn-MoS2 QDs for Targeted MR Imaging and Fluorescence Labelling of Renal Cell Carcinoma [Corrigendum]

Codelivery of Doxorubicin and MDR1-siRNA by Mesoporous Silica Nanoparticles-Polymerpolyethylenimine to Improve Oral Squamous Carcinoma Treatment [Corrigendum]

Correction: Catalase-like Metal–organic Framework Nanoparticles to Enhance Radiotherapy in Hypoxic Cancer and Prevent Cancer Recurrence

Correction: Radiopharmaceutical-activated silicon naphthalocyanine nanoparticles towards tumor photodynamic therapy

Correction to “renal Clearable Bi–Bi2S3 Heterostructure Nanoparticles for Targeting Cancer Theranostics”

Correction: Highly Penetrative Liposome Nanomedicine Generated by a Biomimetic Strategy for Enhanced Cancer Chemotherapy.